Showing items 501–600
Selective inhibition of polyglutamine protein expression
Application US-8901095-B2
United States of America
Antisense modulation of fibroblast growth factor receptor 4 expression
Grant US-8895529-B2
United States of America
Myostatin inhibition for enhancing muscle and/or improving muscle function
Grant US-8895309-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-8883996-B2
United States of America
Modulation of diacylglycerol acyltransferase 2 expression
Grant US-8883997-B2
United States of America
Small activating RNA molecules and methods of use
Grant US-8877721-B2
United States of America
Self-assembled polynucleotide structure
Grant US-8877438-B2
United States of America
Genetic variants contributing to risk of prostate cancer
Grant US-8865400-B2
United States of America
Antisense modulation of kinesin-like 1 expression
Grant US-8865884-B2
United States of America
Antisense modulation of GCGR expression
Grant US-8865674-B2
United States of America
Susceptibility variants for lung cancer
Grant US-8828657-B2
United States of America
Modulation of signal transducer and activator of transcription 3 (STAT3)expression
Grant US-8816056-B2
United States of America
Double-stranded oligonucleotides
Grant US-8815821-B2
United States of America
Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm
Grant US-8808985-B2
United States of America
Compositions and methods for inhibiting expression of the PCSK9 gene
Grant US-8809292-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-8809515-B2
United States of America
Genetic markers associated with risk of diabetes mellitus
Grant US-8796182-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-8796444-B2
United States of America
Genetic markers for risk management of atrial fibrillation and stroke
Grant US-8795963-B2
United States of America
EMP2 antibodies and methods of use thereof for causing regression of a solid tumor or…
Grant US-8785602-B2
United States of America
SiRNA-mediated gene silencing
Grant US-8779116-B2
United States of America
EMP2 antibodies and methods of use thereof causing regression of a solid tumor or…
Grant US-8779104-B2
United States of America
Modulation of eIF4E-BP1 expression
Grant US-8778900-B2
United States of America
Modification of MYD88 splicing using modified oligonucleotides
Grant US-8765703-B2
United States of America
Inhibition of apoptosis-specific eIF-5A(eIF-5A1″) with antisense oligonucleotides and…
Grant US-8754057-B2
United States of America
Modulation of factor 11 expression
Grant US-8735370-B2
United States of America
Gene silencing
Grant US-8729339-B2
United States of America
Method and medicament for inhibiting the expression of a given gene
Grant US-8729037-B2
United States of America
Photobioreactor
Grant US-8728783-B2
United States of America
Transgenic photosynthetic microorganisms
Grant US-8728821-B2
United States of America
Modulation of stat5 expression
Grant US-8722873-B2
United States of America
Compositions and methods for silencing Ebola virus gene expression
Grant US-8716464-B2
United States of America
Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associa…
Grant US-8703930-B2
United States of America
Diagnosis and treatment of disease
Grant US-8697860-B1
United States of America
Compositions and methods for non-parenteral delivery of oligonucleotides
Grant US-8691785-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-8691786-B2
United States of America
Nucleic acid aptamers
Grant US-8685937-B2
United States of America
Agent for targeting c-Jun mRNA
Grant US-8686128-B2
United States of America
RNA interference for the treatment of gain-of-function disorders
Grant US-8680063-B2
United States of America
Compounds and methods for modulating expression ApoB
Grant US-8673871-B2
United States of America
Modulation of apolipoprotein (a) expression
Grant US-8673632-B2
United States of America
Modulation of prion expression
Application US-8669102-B2
United States of America
Methods for treating hypercholesterolemia
Grant US-8664190-B2
United States of America
Methods of controlling tumorigenesis and diagnosing the risk thereof
Grant US-8663915-B2
United States of America
Triggered covalent probes for imaging and silencing genetic expression
Grant US-8658780-B2
United States of America
Antisense modulation of PTP1B expression
Grant US-8658783-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-8658356-B2
United States of America
Modulation of angiopoietin-like 3 expression
Grant US-8653047-B2
United States of America
Antisense modulation of apolipoprotein B-expression
Grant US-RE44760-E1
United States of America
Prevention of chlamydia infection using SIRNA
Grant US-8648052-B2
United States of America
Modulation of Hepatitis B virus (HBV) expression
Grant US-8642752-B2
United States of America
Modulation of glucagon receptor expression
Grant US-8642753-B2
United States of America
Modulation of growth hormone receptor expression and insulin-like growth factor expression
Grant US-8637484-B2
United States of America
Hepcidin, hepcidin antagonists and methods of use
Grant US-8629250-B2
United States of America
Modulation of growth hormone receptor expression and insulin-like growth factor expression
Grant US-8623836-B2
United States of America
Antisense oligonucleotide modulation of STAT3 expression
Grant US-8623643-B2
United States of America
SiRNA silencing of genes expressed in cancer
Grant US-8598333-B2
United States of America
Method of producing a fermentable sugar
Grant US-8597914-B2
United States of America
Transgenic photosynthetic microorganisms
Grant US-8597951-B2
United States of America
Compounds and methods for modulating expression of PTP1B
Grant US-8586554-B2
United States of America
Modulation of forkhead box O1A expression
Grant US-8580948-B2
United States of America
Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and…
Grant US-8580488-B2
United States of America
Method and means for treatment of osteoarthritis
Application US-8574857-B2
United States of America
Small nucleic acid activator specifically enhancing miR-34a promoter transcriptional…
Application CN-103320439-A
China
Methods for modulating expression of RBP4
Grant US-8541388-B2
United States of America
Modulation of SMRT expression
Grant US-8541387-B2
United States of America
Methods and compositions for transdermal delivery of nucleotides
Application US-8530436-B2
United States of America
Modulation of apolipoprotein C-III expression
Grant US-8530439-B2
United States of America
siRNA sequence-independent modification formats for reducing off-target phenotypic…
Grant US-8524681-B2
United States of America
High potency siRNAS for reducing the expression of target genes
Grant US-8524680-B2
United States of America
Modulation of STAT 6 expression
Grant US-8518904-B2
United States of America
Modulation of HIF1α and HIF2α expression
Grant US-8513400-B2
United States of America
Modified siRNA molecules and uses thereof
Grant US-8513403-B2
United States of America
Hybridization chain reaction amplification for in situ imaging
Grant US-8507204-B2
United States of America
Triggered RNAi
Grant US-8497364-B2
United States of America
Antisense modulation of fibroblast growth factor receptor 4 expression
Grant US-8486904-B2
United States of America
Methods and compositions for treating keratin hyperproliferative disorders
Grant US-8476243-B2
United States of America
Antisense modulation of kinesin-like 1 expression
Grant US-8470795-B2
United States of America
EXOSOMES WITH TRANSFERRIN PEPTIDES
Application WO-2013084001-A1
World Intellectual Property Organisation (WIPO)
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses…
Application EP-2602332-A1
European Patent Office
Compositions and methods for silencing genes involved in hemorrhagic fever
Grant US-8455455-B1
United States of America
Compositions and their uses directed to diacylglycerol acyltransferase 1
Grant US-8455456-B2
United States of America
Aminoalcohol lipidoids and uses thereof
Grant US-8450298-B2
United States of America
Antibody to GDF8 and uses thereof
Grant US-8415459-B2
United States of America
Compositions and their uses directed to huntingtin
Application US-8415465-B2
United States of America
Compositions and their uses directed to gemin genes
Grant US-8409856-B2
United States of America
Modulation of eIF4E expression
Grant US-8410074-B2
United States of America
Compositions and methods for non-parenteral delivery of oligonucleotides
Grant US-8377897-B2
United States of America
Compounds and methods for modulating expression of GCCR
Grant US-8372967-B2
United States of America
Transgenic photosynthetic microorganisms and photobioreactor
Application US-8367379-B2
United States of America
Compositions and methods for modulation of SMN2 splicing
Grant US-8361977-B2
United States of America
Compounds and methods for modulating expression of SGLT2
Grant US-8362232-B2
United States of America
Modulation of factor 11 expression
Grant US-8334372-B2
United States of America
SiRNA-mediated gene silencing
Grant US-8329890-B2
United States of America
Methods and compositions for enhancing the efficacy and specificity of RNA silencing
Grant US-8329892-B2
United States of America
Methods, agents, and compound screening assays for inducing differentiation of…
Grant US-8318137-B2
United States of America
Triggered RNAi
Grant US-8318921-B2
United States of America
Cancer-cell-specific cell proliferation inhibitors
Grant US-8314073-B2
United States of America
Allele-specific RNA interference
Grant US-8309533-B2
United States of America
Showing items 501–600